Xanthus Pharmaceuticals

company

About

Xanthus is a biopharmaceutical company.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$25M
Industries
Biopharma,Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$55.80M
Xanthus Pharmaceuticals has raised a total of $55.80M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2006 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 1, 2006 Series B $25M 1 Detail
Dec 12, 2003 Series B $30.80M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Xanthus Pharmaceuticals is funded by 1 investors. CDP Capital Technology Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
CDP Capital Technology Ventures Series B